Internal Medicine NewsLate-onset neutropenia more common than expected in patients on rituximabSeptember 18, 2020RheumatologyNephrology
Internal Medicine NewsDeaths sky high in hospitalized COVID patients with kidney injurySeptember 9, 2020COVID-19 UpdatesNephrology
Internal Medicine NewsDAPA-CKD: SGLT2 inhibitor benefit extends to chronic kidney disease without diabetesAugust 31, 2020DiabetesCardiologyNephrologyEndocrinology
Internal Medicine NewsSGLT2 inhibitors have a breakout yearAugust 6, 2020DiabetesCardiologyEndocrinologyNephrology
Internal Medicine NewsReal-world data show SGLT2 inhibitors for diabetes triple DKA riskJuly 29, 2020DiabetesEndocrinologyNephrologyCardiology
Internal Medicine NewsTerlipressin squeaks by FDA review for hepatorenal syndrome 1July 17, 2020GastroenterologyNephrologyRare Diseases
Internal Medicine NewsSGLT2 inhibitors, developed for T2D, now ‘belong to cardiologists and nephrologists’July 16, 2020DiabetesCardiologyNephrology
Internal Medicine NewsDropping race-based eGFR adjustment gains traction in U.S.July 8, 2020NephrologyNephrology
Internal Medicine NewsWhere does dexamethasone fit in with diabetic ketoacidosis in COVID-19?June 22, 2020DiabetesCOVID-19 UpdatesEndocrinologyPulmonologyNephrology
Internal Medicine NewsBelimumab safely improved renal function in lupus nephritis patientsJune 19, 2020RheumatologyNephrology
Internal Medicine NewsDapagliflozin’s T2D renal protection extends to ‘fast decline’ of eGFRJune 18, 2020DiabetesNephrology
Internal Medicine NewsBe vigilant for scleroderma renal crisisJune 15, 2020RheumatologyNephrologyDermatologyRare Diseases
Internal Medicine NewsLarge COVID-19 dataset: Kidney injury in >35% of those in hospitalMay 20, 2020COVID-19 UpdatesNephrology
Internal Medicine NewsProteins in urine may predict active lupus nephritisMay 18, 2020NephrologyRheumatology
Internal Medicine NewsDawn of new lupus nephritis treatment after AURORA trialMarch 30, 2020RheumatologyNephrology